Jim Easton Consortium - Project 4: Biomarkers in Familial Alzheimer's Disease (FAD)

Research suggests that brain changes may occur years before actual Alzheimer's symptoms are detected. The major goal of Biomarkers in Familial Alzheimer's Disease (FAD) is to study these changes in people who carry an Alzheimer's disease (AD) mutation to determine how the disease process develops before there are any symptoms. Ultimately, knowledge gained from Biomarkers in FAD study may lead to tests that detect people who still are normal but are at very high risk of developing dementia caused by Alzheimer's disease.